FH and leiomyoma: Although the severity of pain is variable, approximately 20% of patients report moderate to severe impairment in quality of life.1 When cutaneous leiomyomas are suspected, a biopsy should be performed to confirm the diagnosis, followed by molecular genetic analysis of the FH gene.